Recent advances for the management of Raynaud phenomenon using botulinum neurotoxin A

J Hand Surg Am. 2011 Oct;36(10):1708-10. doi: 10.1016/j.jhsa.2011.07.011. Epub 2011 Sep 8.

Authors

Sandeep Mannava¹, Johannes F Plate, Austin V Stone, Thomas L Smith, Beth P Smith, L Andrew Koman, Christopher J Tuohy

Affiliation

¹ Wake Forest University School of Medicine, Department of Orthopaedic Surgery, Medical Center Boulevard, Winston-Salem, NC 27157-1070, USA. smannava@wakehealth.edu

PMID: 21903346
DOI: 10.1016/j.jhsa.2011.07.011

No abstract available

Publication types

Review

MeSH terms

Botulinum Toxins, Type A / administration & dosage*
Botulinum Toxins, Type A / adverse effects
Humans
Injections
Neuromuscular Agents / administration & dosage*
Raynaud Disease / therapy*

Substances

Neuromuscular Agents
Botulinum Toxins, Type A